What are you looking for?
Catalan multinational will collect plasma from recovering covid-19 patients with aim of producing hyperimmune antibodies
Tech & Science
Grífols claims clinical trial suggests reduction in disease's progression
Catalan pharmaceutical multinational’s revenue grows to 1,023 million euros in first three months of year
Although the company has “no plans” to leave Catalonia, if politics affects business it will have to take "necessary measures"